메뉴 건너뛰기




Volumn 103, Issue , 2013, Pages 455-462

Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery

Author keywords

Aceclofenac; Anti inflammatory; Nanoparticle; PMN

Indexed keywords

ACECLOFENAC; ANTI-INFLAMMATORIES; CORNEAL DAMAGE; CRYSTALLINITIES; DRUG ENTRAPMENT; ENTRAPMENT EFFICIENCY; EUDRAGIT; IN-VITRO; IN-VIVO; NANOPARTICLE FORMULATION; NANOPARTICULATE SYSTEM; NANOPRECIPITATION; OCULAR DELIVERY; PARTICLE MORPHOLOGIES; PMN; POLYDISPERSITY INDICES; POLYMORPHONUCLEAR LEUKOCYTES; POWDER X RAY DIFFRACTION; ROOM TEMPERATURE; SHELF LIFE; SQUARE-ROOT;

EID: 84871103755     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.10.056     Document Type: Article
Times cited : (90)

References (35)
  • 11
    • 0007879864 scopus 로고
    • Controlled Drug Bioavailability
    • John Wiley & Sons, New York, V.F. Smolen, L. Bull (Eds.)
    • Schoenwald R.D. Controlled Drug Bioavailability. Bioavailability Control by Drug Delivery System Design 1985, vol. 3:257-306. John Wiley & Sons, New York. V.F. Smolen, L. Bull (Eds.).
    • (1985) Bioavailability Control by Drug Delivery System Design , vol.3 , pp. 257-306
    • Schoenwald, R.D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.